Atlas Trials

A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma

Clinical trial NCT00434642 · COMPLETED

Trial details

NCT number
NCT00434642
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2007-04-01
Primary completion
2010-09-01
Enrollment
484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.